"It is often only by puncture biopsy of the liver that a precise diagnosis can be made and when diagnosis is doubtful, treatment, advice and prognosis are apt to be hesitant, and perhaps as a consequence, the handling of the patient ineffective." H P Himsworth, 1950' Thirty years on, this statement remains true: and with its widespread application and the development of specialised staining techniques liver biopsy continues to be one of the most important diagnostic procedures in clinical hepatology.
The maximum benefit from the procedure can be obtained, however, only when it is performed by properly trained and experienced personnel and when the histological examination is done by a histopathologist familiar with the morphological appearances of the liver in health and disease. Successful liver biopsy without complications demands good technique, and this applies particularly in patients with cirrhosis, in whom inadequate specimens and serious complications are the hallmarks of the inexperienced operator.
Techniques and types
The choice of technique used to biopsy the liver is dictated by the coagulation state of the patient, the presence of ascites, and whether the liver is cirrhotic or contains an obvious space occupying lesion. The ability of the patient to cooperate during the procedure is a further consideration, and general anaesthesia should be used in children from 2 to 10 years of age and in stuporous or Regardless of the type of needle used percutaneous biopsy is best performed with the patient in the supine position close to and parallel to the edge of the bed, with his right hand positioned behind the head. The site for the biopsy is selected by caudal percussion over the hemithorax between the anterior and midaxillary lines until an intercostal space is reached where dullness is maximal at the end of expiration. The intercostal space below this point is used, and to ensure a painless procedure 5-10 ml of lignocaine 20/ (without adrenaline) is infiltrated, firstly subcutaneously, then into the intercostal area, and finally down to the diaphragm and capsule of the liver, care being taken to infiltrate each layer adequately.
The simplest and thereby safest technique is with the Menghini needle, a suction device which reduces the time spent within the liver substance to less than a second. The needle is 6 cm long with an oblique tip slightly convex towards the outside, and a retaining device is incorporated in its proximal end to prevent liver tissue being aspirated into the syringe. The diameter of the needle should not exceed 1-4 mm and a penetration limiter should be used for children and thin adult patients. Steady suction is applied to the syringe connected to the needle and the patient asked to exhale fully. The needle is then advanced into the liver and rapidly withdrawn. The specimen is discharged from the needle into a 1000 formaldehyde solution.
The Tru-Cut biopsy needle is a disposable modification of the Vim-Silverman obturator and cannula; an obturator with a pointed end and a cannula are integrated into an all in one design. The device is advanced 2 to 3 cm into the liver substance in the closed position, the obturator is advanced holding the outer cutting sheath steady, and finally the sheath is advanced to cut the liver and the whole assembly is withdrawn. The entire manoeuvre should take less than three seconds, and specimens 1 mm in diameter and 1-2 cm in length are usually obtained.
After biopsy the patient should be monitored carefully for haemorrhage and other complications, with half hourly recordings of pulse rate and blood pressure for two hours and then hourly recordings for four hours. In Britain until relatively recently liver biopsy was considered an inpatient procedure requiring rest and observation in bed for 24 hours. Studies from North America on a total of 829 patients have shown, however, that the procedure may be carried out safely without serious complications on a day case basis with observation after the biopsy for three hours. 
Diffuse parenchymal liver
Patients are commonly referred after detection on medical screening of abnormalities of liver function values. Most often the abnormalities are related to alcohol intake. Histological confirmation of the diagnosis is important in establishing the severity of damage since the management of such patients will depend on whether the lesion is reversible (fatty infiltration), precirrhotic (alcoholic hepatitis), or irreversible (cirrhosis). In the last two stages of the disease maintained abstinence is imperative if the patient is to avoid the development of cirrhosis and the complications of established portal hypertension such as variceal haemorrhage. Abnormal liver function values may also be found on biopsy to be due to other forms of chronic liver disease such as primary biliary cirrhosis or chronic active hepatitis. Another important diagnostic category with implications for treatment is diffuse malignant infiltration with, for example, lymphoma; in such patients liver biopsy will establish the diagnosis and stage the disease. The presence of granulomatous hepatitis can be confirmed only with liver biopsy, which in a few instances will also establish its aetiology. In Britain most such patients have sarcoidosis or tuberculosis, though there are many other causes, and detailed investigations may be needed.8 Intrahepatic cholestasis, presenting clinically as an "obstructive" type jaundice, may usually be distinguished from mechanical obstruction of the biliary tree by the absence of ductal dilatation on ultrasound examination. Several other liver diseases, however, may present with cholestatic features, most notably primary biliary cirrhosis and alcoholic liver disease. Primary sclerosing cholangitis may be diagnosed on the liver biopsy appearances-though in this condition and in most of the other types of intrahepatic cholestasis endoscopic retrograde cholangiography is required as well as liver biopsy.
The likely aetiology and stage of different varieties of chronic hepatitis need to be established so that treatment may be planned. Patients with the histological features of chronic persistent hepatitis-minimal parenchymal necrosis and a mild to moderate lymphocytic infiltration confined to the portal tracts-have an excellent long term prognosis; indeed, though resolution may be delayed for many years, most such patients eventually recover, and treatment is unnecessary.9 Since, however, a few patients (particularly those with HBsAg positive and non-A, non-B chronic persistent hepatitis) may progress to chronic active hepatitis biopsy should be repeated at two year intervals-or earlier if deterioration in liver function occurs. The prognosis of chronic active hepatitis is poor, particularly when severe parenchymal (piecemeal) necrosis is associated with bridging or multilobular collapse.'0 The importance of diagnosing this form of chronic active hepatitis lies in its response to corticosteroids. Treatment gives a definite improvement in survival, particularly in those patients with the HBsAg negative "autoimmune" variant of chronic active hepatitis."1 The goal of treatment is resolution of inflammatory activity, and though improvement in the results of liver function tests gives a general guide to the effects of treatment, only histological examination allows an accurate assessment of disease activity. Liver biopsy in such patients at roughly one to two year intervals permits reduction in the dosage of corticosteroids to the lowest possible levels necessary for control of disease. Since most such patients require corticosteroids long term12 (they develop reactivation of disease when these are withdrawn) the minimum dosage must be used if serious side effects are to be avoided.
The histological appearances of chronic active hepatitis may be seen in several other conditions, including x, antitrypsin deficiency and Wilson's disease. The latter is an important and remediable cause of liver disease in young patients, and the copper content of the biopsy specimen, taken in a copper free container, should be determined if the diagnosis is suspected.
Complications
Reviews of large series of patients show a mortality of between 00150o and 170'o13-15 and an incidence of major complications of 0-32. 0.14 Transient pain in the tip of the shoulder lasting a few hours and epigastric discomfort during and after the biopsy are common; they require treatment with paracetamol only. More severe and persistent pain, particularly in the right hypochondrium, is likely to indicate a subcapsular accumulation of blood or bile, and the sudden onset of very severe pain suggests billary peritonitis.
Intraperitoneal haemorrhage is the most frequently encountered serious complication; it usually results from puncture of the arterial tree within the liver or porta hepatis, though it may also be due to perforation of distended external portal vein radicles in patients with cirrhosis. Terry observed clinically significant haemorrhage in 0-2" of 7532 biopsies; four patients required laparotomy, but no deaths were recorded.14 Lindner reported 67 incidents of bleeding after 80 000 biopsies with the Menghini needle with 22 deaths,'3 and our own experience is similar using the Tru-Cut needle-one death and eight laparotomies in 4000 biopsies. Haemorrhage after biopsy should initially be managed with blood transfusion, but when there is persistent hypotension and increasing abdominal distension laparotomy is indicated. Haematobilia, a rare complication of liver biopsy, may be manifested at anything between one and 21 days after the procedure. It results from simultaneous perforation of closely approximated intrahepatic vascular and biliary tree radicles with the development of a persistent communication between these structures. The characteristic clinical syndrome consists of recurrent episodes of biliary colic and jaundice in association with melaena. Retrograde cholangiography or hepatic arteriography or both will establish the diagnosis and localise the bleeding point, which may be treated either by arterial embolisation or, if this fails, by direct surgical ligation of the affected vessel. Prospective screening with liver scintiscans before and after biopsy have shown that localised intrahepatic haematomas are common after what appears to have been an uncomplicated biopsy.'6 Occasionally these may become clinically apparent when they are of sufficient size to produce persistent pain or obstruction of the biliary tree. Haemorrhage into the pleural cavity has been reported as a result of pleural trauma or perforation of an intercostal artery. Such arterial damage can be avoided by inserting the needle close to the lower border of the intercostal space.
Bile peritonitis is almost entirely preventable by prebiopsy ultrasound screening, since it is seen most commonly in the presence of biliary obstruction. It may still occur, however, in the occasional patient in whom biliary obstruction is present in the absence of ductal dilatation and in patients with unusually positioned gall bladders-a problem seen particularly in patients with small cirrhotic livers. The patient develops severe localised or generalised abdominal pain and hypotension within minutes of the procedure. Biliary peritonitis is usually self limiting and should be managed conservatively with analgesia and antibiotics to prevent secondary infection; only very occasionally is surgical intervention required. Transient bacteraemia has been observed in up to 130/ of patients undergoing liver biopsy and patients with valvular heart disease should receive prophylactic antibiotic cover.'7 J E HEGARTY 
